Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irwin D Bernstein

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Clinical Lymphoma|April 24, 2002
CD33 as a target for selective ablation of acute myeloid leukemiaIrwin D Bernstein
British Journal of Haematology|April 17, 2004
Establishment of a pluripotent preleukaemic stem cell line by expression of the AML1-ETO fusion protein in Notch1-immortalized HSCN1cl10 cellsColleen Delaney, Irwin D Bernstein
Cell Stem Cell|February 7, 2012
Engineering stem cell expansionIrwin D Bernstein, Colleen Delaney
Blood|October 13, 2017
Gemtuzumab ozogamicin for acute myeloid leukemiaFrederick R Appelbaum, Irwin D Bernstein
Blood|February 2, 2013
Visualizing human ESC-derived hematopoiesisBrandon K Hadland, Irwin D Bernstein
Blood|March 26, 2011
Ex vivo expansion of human hematopoietic stem and progenitor cellsAnn Dahlberg, Colleen Delaney, Irwin D Bernstein
The Journal of Clinical Investigation|October 24, 2002
Delta-1 enhances marrow and thymus repopulating ability of human CD34(+)CD38(-) cord blood cellsKohshi Ohishi, Barbara Varnum-Finney, Irwin D Bernstein
Blood|November 2, 2002
Combined effects of Notch signaling and cytokines induce a multiple log increase in precursors with lymphoid and myeloid reconstituting abilityBarbara Varnum-Finney, Carolyn Brashem-Stein, Irwin D Bernstein
Trends in Molecular Medicine|January 30, 2002
Antibody-directed therapies for hematological malignanciesMichael L Linenberger, David G Maloney, Irwin D Bernstein
Blood|December 1, 2007
Notch target Hes5 ensures appropriate Notch induced T- versus B-cell choices in the thymusBarbara Varnum-Finney, Mari H Dallas, Keizo Kato, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Clinical Lymphoma|April 24, 2002
CD33 as a target for selective ablation of acute myeloid leukemiaIrwin D Bernstein
British Journal of Haematology|April 17, 2004
Establishment of a pluripotent preleukaemic stem cell line by expression of the AML1-ETO fusion protein in Notch1-immortalized HSCN1cl10 cellsColleen Delaney, Irwin D Bernstein
Cell Stem Cell|February 7, 2012
Engineering stem cell expansionIrwin D Bernstein, Colleen Delaney
Blood|October 13, 2017
Gemtuzumab ozogamicin for acute myeloid leukemiaFrederick R Appelbaum, Irwin D Bernstein
Blood|February 2, 2013
Visualizing human ESC-derived hematopoiesisBrandon K Hadland, Irwin D Bernstein
Blood|March 26, 2011
Ex vivo expansion of human hematopoietic stem and progenitor cellsAnn Dahlberg, Colleen Delaney, Irwin D Bernstein
The Journal of Clinical Investigation|October 24, 2002
Delta-1 enhances marrow and thymus repopulating ability of human CD34(+)CD38(-) cord blood cellsKohshi Ohishi, Barbara Varnum-Finney, Irwin D Bernstein
Blood|November 2, 2002
Combined effects of Notch signaling and cytokines induce a multiple log increase in precursors with lymphoid and myeloid reconstituting abilityBarbara Varnum-Finney, Carolyn Brashem-Stein, Irwin D Bernstein
Trends in Molecular Medicine|January 30, 2002
Antibody-directed therapies for hematological malignanciesMichael L Linenberger, David G Maloney, Irwin D Bernstein
Blood|December 1, 2007
Notch target Hes5 ensures appropriate Notch induced T- versus B-cell choices in the thymusBarbara Varnum-Finney, Mari H Dallas, Keizo Kato, et al.
Pageof 8